These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9727990)

  • 1. Multidrug resistant tuberculosis in France 1992-4: two case-control studies.
    Schwoebel V; Decludt B; de Benoist AC; Haeghebaert S; Torrea G; Vincent V; Grosset J
    BMJ; 1998 Sep; 317(7159):630-1. PubMed ID: 9727990
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance in pulmonary tuberculosis in Istanbul.
    Kilicaslan Z; Albal H; Kiyan E; Aydemir N; Seber E
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):763-4. PubMed ID: 12415480
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
    Ershova JV; Volchenkov GV; Kaminski DA; Somova TR; Kuznetsova TA; Kaunetis NV; Cegielski JP; Kurbatova EV
    Emerg Infect Dis; 2015 Nov; 21(11):2048-51. PubMed ID: 26488585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
    Crudu V; Arnadottir T; Laticevschi D
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of tuberculosis].
    Rev Mal Respir; 2003 Dec; 20(6 Pt 2):S13-9. PubMed ID: 15101324
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of primary drug-resistant pulmonary tuberculosis in immunocompromised patients.
    Jiang JR; Yen SY; Wang JY
    Respirology; 2011 Feb; 16(2):308-13. PubMed ID: 21077990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
    Grishin MN; Svistov VV; Krivoshein IuS
    Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
    Tahaoğlu K; Kizkin O; Karagöz T; Tor M; Partal M; Sadoğlu T
    Tuber Lung Dis; 1994 Oct; 75(5):324-8. PubMed ID: 7841424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Household screening and multidrug-resistant tuberculosis.
    Cox H; van Cutsem G
    Lancet; 2011 Jan; 377(9760):103-4. PubMed ID: 21145582
    [No Abstract]   [Full Text] [Related]  

  • 12. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilot study on multidrug resistant tuberculosis in Nigeria.
    Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO
    Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
    Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, control and treatment of multidrug-resistant tuberculosis.
    Chaulet P; Raviglione M; Bustreo F
    Drugs; 1996; 52 Suppl 2():103-7; discussion 107-8. PubMed ID: 8869846
    [No Abstract]   [Full Text] [Related]  

  • 16. Programmatic management of multidrug-resistant tuberculosis--15 years later.
    Nardell EA
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1280. PubMed ID: 22283883
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis reaches new milestones, good and bad.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2015 Dec; 15(12):1361. PubMed ID: 26607114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.